Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Operating Income 2020–2025
Aldeyra Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aldeyra Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -3.5 M, a 65.98% decrease year-over-year.
- Aldeyra Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -28.4 M.
- Aldeyra Therapeutics Inc. annual operating income for 2025 was -35.3 M, a 41.34% decrease from 2024.
- Aldeyra Therapeutics Inc. annual operating income for 2024 was -60.1 M, a 40.48% increase from 2023.
- Aldeyra Therapeutics Inc. annual operating income for 2023 was -42.8 M, a 31.73% decrease from 2022.
- Aldeyra Therapeutics Inc. annual operating income for 2022 was -62.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aldeyra Therapeutics Inc. Operating Income — FAQ
Aldeyra Therapeutics Inc. (ALDX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Aldeyra Therapeutics Inc.'s operating income?
Aldeyra Therapeutics Inc. (ALDX) reported operating income of -$35M for fiscal 2025.
Where can I see ALDX's operating income history?
The chart and table above show Aldeyra Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.